ArticleJACC. Advances2026
Characteristics, Management, and Outcomes of Diabetes Subtypes in Patients With Cardiogenic Shock: A Nationwide Analysis.
Article in JACC. Advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere is a gap in current research looking at differences between diabetes subtypes in the setting of cardiogenic shock (CS).
objectivesThe authors sought to evaluate differences in characteristics, management, and outcomes between patients with no diabetes mellitus (DM), type 1 DM (T1DM), and type 2 DM (T2DM) admitted with CS.
methodsThe National Readmissions Database was utilized to identify patients between 2016 and 2021 with any discharge diagnosis of CS. The cohort was divided into 3 groups: CS without DM, CS with T1DM, and CS with T2DM. The primary outcomes were all-cause in-hospital mortality and 30-day readmissions.
resultsA total of 1,073,340 patients hospitalized with CS were identified during the study period, of which 644,768 (60.0%) had no DM, 10,423 (1.0%) had T1DM, and 418,149 (39.0%) had T2DM. Those with T1DM were more likely to present with CS due to acute myocardial infarction and undergo invasive evaluation with left heart catheterization compared to those with T2DM and no DM. In-hospital mortality was higher among those with T1DM (adjusted OR: 1.16; 95% CI: 1.09-1.24) and T2DM (adjusted OR: 1.08; 95% CI: 1.07-1.10) compared to those without DM, and both groups were more likely to be readmitted within 30 days. Among patients with CS from acute myocardial infarction, in-hospital mortality was similar between patients with T1DM and no DM, but higher in those with T2DM.
conclusionsPatients with DM, particularly T1DM, who present with CS represent a high-risk cohort with greater in-hospital mortality and higher readmission rates compared to patients without DM.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.